Navigation Links
knowledge of proliferative sickle cell retinopathy can help Prevent eye trauma

Sickle cell disease is an inherited blood disorder that affects the hemoglobin protein found in red blood cells. Visual loss has been reported in 10- 20% of eyes in patients with this disease, a high figure that // may reflect ascertainment bias towards detecting patients with symptoms. Proliferative sickle cell retinopathy (PSR) is the principal contributor to visual loss, but the patients remain asymptomatic unless traumatic complications such as vitreous hemorrhage or retinal detachment (RD) occur.

A recent study, to be published in the November issue of Ophthalmology, details a longitudinal study done over 20 years to describe the incidence, prevalence, and natural history of proliferative sickle cell retinopathy (PSR) in a patient population free from the bias of symptomatic referral, followed from birth.

This work, supported by the Wellcome Trust, London, United Kingdom, confirms a greater incidence and severity of PSR in sickle cell disease, and shows that spontaneous regression occurred in 32% of PSR-affected eyes. Permanent visual loss was uncommon in subjects observed up to the age of 26 years. The discrepancy between the frequency of PSR, which concerns the ophthalmologist, and that of visual loss, which concerns the patient, raises a note of caution. It calls into question the justification of routine screening and prophylactic treatment, particularly if it is directed towards prevention of permanent visual loss rather than transient loss from hemorrhage.

Knowledge of the natural history of PSR is essential because the prevention of this visual loss and eye trauma is dependent on the early detection and treatment of proliferative sickle cell retinopathy.
'"/>




Page: 1

Related medicine news :

1. Spreading knowledge to doctors about herbal medicine
2. Guidant sold defective defibrillators with full knowledge
3. India set to become the global knowledge hub
4. New law to protect traditional knowledge
5. Zinc may enhance growth in Young sickle cell patients
6. Gene to identify risk of stroke in sickle cell anemia
7. New treatment for babies with sickle cell anemia
8. Diabetic retinopathy in pre-diabetes conditions
9. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
10. Prevention is better than cure
11. Prevention of cataracts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Venture Construction ... Classic Tournament held on June 20th at the Woodmont Country Club at 1201 ... Wings, an organization dedicated to helping service members that have been wounded in battle ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: